Late-onset anaphylaxis to omalizumab reported.(News) From: Skin & Allergy News | Date: June 1, 2006| Author: | COPYRIGHT 2006 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information) Copyright information

MIAMI BEACH -- Two patients developed anaphylaxis to the popular allergic asthma medication omalizumab after months of successful treatment, Dr. Kursteen Price reported in a poster at the annual meeting of the American Academy of Allergy, Asthma, and Immunology.

This is the first report of late-onset anaphylaxis to the humanized monoclonal anti-immunoglobulin E (IgE) antibody, she said. According to the prescribing information for omalizumab (Xolair), "anaphylaxis has occurred within 2 hours of the first or subsequent administration of Xolair in 3 [less than 0.1%] patients ...

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

	Asthma rx, omalizumab, tied to late-onset anaphylaxis.(News) Magazine article from: Family Practice News ; ...asthma medication omalizumab after months of...first report of late-onset anaphylaxis to the humanized...information for omalizumab (Xolair), anaphylaxis...anaphylaxis to omalizumab would not occur...That is because omalizumab decreases IgE...is present in omalizumab. ...
	Omalizumab in severe chronic urticaria Magazine article from: Indian Journal of Dermatology, Venereology and Leprology ; ...describe here a patient who responded to omalizumab after failure to respond to cyclosporine...100. At this stage, she was started on omalizumab 300 mg every four weeks in consultation...symptoms, which lasted for four weeks. Omalizumab, a recombinant, humanized, monoclonal...
	Xolair Magazine article from: Formulary ; Omalizumab GENETECH/NOVARTIS/TANOX First biologic approved for the treatment of allergic asthma Omalizumab, a recombinant DNA-derived humanized IgG1[kappa] monoclonal...persistent asthma. Efficacy. The safety and efficacy of omalizumab was evaluated in 3 randomized, double-blind, placebo-controll...
	Omalizumab appears effective in patients with poorly controlled allergic asthma Magazine article from: Formulary ; ...investigational anti-immunoglobulin-E drug omalizumab experienced about half the number of...open-label study, patients receiving add-on omalizumab had an annualized rate of 4.92 events...206 patients into the trial to receive omalizumab, a compound designed to reduce circulating...
	Omalizumab therapy found to quell symptoms of urticaria, food allergy.(Dermatologic Therapy)(Clinical report) Magazine article from: Skin & Allergy News ; ...Asthma, and Immunology. The antibody, omalizumab, probably is effective for urticaria...mast cells has in causing the disorder. Omalizumab is a recombinant, humanized antibody...randomized to treatment with either omalizumab or placebo at Johns Hopkins Medical...
	Omalizumab pretreatment may boost immunotherapy's safety.(Clinical Rounds) Magazine article from: Family Practice News ; Keystone, Colo. -- Pretreatment with omalizumab to decrease acute systemic reactions...reactions appears to be pretreatment with omalizumab (Xolair), a humanized monoclonal IgE...allergic rhinitis received 9 weeks of omalizumab or placebo followed by 1 day of rush...
	Rush immunotherapy safer with omalizumab pretreatment.(Disease/Disorder overview) Magazine article from: Internal Medicine News ; KEYSTONE, COLO. -- Pretreatment with omalizumab to decrease acute systemic reactions...reactions appears to be pretreatment with omalizumab (Xolair), a humanized monoclonal IgE...allergic rhinitis received 9 weeks of omalizumab or placebo followed by 1 day of rush...
	Stronger warning urged for asthma drug Magazine article from: Healthcare Traveler ; ...reactions following the administration of omalizumab (Xolair) have prompted the FDA to request...reactions have been associated with omalizumab, an injectable drug that blocks the...develop anaphylaxis after any dose of omalizumab, even if no reaction occurred after...
	Xolair anaphylaxis risk added to label Magazine article from: Drug Topics ; ...boxed warning label has been added for omalizumab (Xolair, Genentech), and the Warnings...cases occurred after the first dose of omalizumab, 19% followed the second dose, and 10...occurred after 29 doses. Therefore, omalizumab should be administered to patients only...
	New warning for asthma therapy Magazine article from: Drug Topics ; Omalizumab (Xolair, Genentech) labeling will now include a black...and hives. The reaction can occur after any dose of omalizumab and may be delayed up to 24 hours after the dose is...that strengthen the existing warning for anaphylaxis. Omalizumab is approved for the treatment of adults and adolescents...

For more facts and information, see all results

Find more facts and information related to the article "Late-onset anaphylaxis to omalizumab ..."